Ypsomed and Terumo Corporation agree on collaboration

Press Releases Ypsomed Group

Burgdorf – Terumo Corporation a Japanese global operating medical technology group plans to supplement its range of products and services towards the pharmaceutical industry and integrate its prefillable polymer syringe PLAJEX™ into Ypsomed's autoinjector YpsoMate®. The first pharma customer has already placed an order for this new offering, with further customers expected.

Read more...

Ypsomed newly supplies AstraZeneca with the Bydureon Pen

Press Releases Ypsomed Group

Burgdorf – Starting in the US from September 2014, the glucagon-like peptide-1 (GLP-1) receptor agonist exenatide will be administered with the dual-chamber injection system Bydureon Pen, based on Ypsomed's LyoTwist® platform.

Read more...

Ypsomed increases dividends to shareholders by 50%

Press Releases Ypsomed Group

Burgdorf – Annual general meeting of July 1, 2014.

Read more...

Ypsomed strengthens sales in its business segments

Press Releases Ypsomed Group

Burgdorf – Injection Systems and Diabetes Care to be managed separately.

Read more...

Ypsomed 2013/14 business year: report and press release

Press Releases Ypsomed Group

Burgdorf – Ypsomed successfully implements turnaround strategy and signs three new Injection Systems contracts with GlaxoSmithKline (GSK), Palatin Technologies, Inc. and Pharmstandard.

Read more...